IRENE AMBE-NGUNI: Open Payments
NPI 1740506971 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 24 payments from 15 companies in 2025. Trend: 2023 $871 · 2024 $110 · 2025 $495
Food & beverage: $396Education: $99
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Janssen Biotech, Inc. | 3 | $48 |
| Eisai Inc. | 2 | $33 |
| GENZYME CORPORATION | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Legend Biotech USA Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $18 |
Products named: FOTIVDA, KEYTRUDA, Fabhalta, Lenvima, DARZALEX, KISQALI, OJJAARA, JAKAFI.
Industry payments across NJ — which companies pay providers there.
